Lisbeth Robinson

Patent Attorney

Lisbeth Robinson joins Billion & Armitage after serving as a patent examiner in Technology Center 1600 of the United States Patent and Trademark Office. Her docket encompassed applications within Biotechnology and Organic Chemistry fields, with emphasis in pharmaceutical, cosmetic, and agricultural formulations.  Prior to joining the USPTO she prosecuted patent applications for transgenic plants, cardiovascular devices, and diagnostic methods as a Life Sciences Associate of Fish and Richardson, P.C. Lisbeth received a bachelor’s degree in Biochemical Sciences from the University of Vermont, a PhD from the University of Minnesota (“Improved Optical Highlighters Derived From Dsred Variants and Enhanced Calcium Leak from Endoplasmic Reticulum Calcium Stores Induced by Hepatitis C Virus NS5A Protein”, Advisor: Dr. Jonathan Marchant), and a Juris Doctor from the University of Minnesota Law School as the first JD/PhD graduate of the Joint Degree Program in Law, Health and the Life Sciences. Lisbeth is licensed to practice law in Minnesota and registered as a Patent Attorney with the USPTO.

  1. Richard E. Billion

    Shareholder

  2. Benjamin C. Armitage

    Shareholder/CEO

  3. Michael A. Collins

    Shareholder

  4. Gregory S. Schwartz

    Attorney

  5. Lisbeth Robinson

    Patent Attorney

  6. John Klos

    Patent Attorney

  7. Robert Ray

    Patent Attorney

  8. Kevin Cyr

    Patent Attorney

  9. Julie A. Shea

    Practice Administrator

  10. Wendy Skelly

    Paralegal

  11. Liz McDermott

    Paralegal